Exp Clin Endocrinol Diabetes 2003; 111(1): 21-26
DOI: 10.1055/s-2003-37496
Article

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Signaling of the Human Calcium-Sensing Receptor Expressed in HEK293-Cells is Modulated by Protein Kinases A and C

J. Bösel 1 , 5 , M. John 2 , M. Freichel 3 , E. Blind 4
  • 1Department of Medicine I - Endocrinology and Metabolism, University of Heidelberg, Heidelberg, Germany
  • 2Novartis Pharma AG - Bone Metabolism, Basel, Switzerland
  • 3Department of Pharmacology and Toxicology, University of the Saarland, Homburg, Germany
  • 4Department of Medicine - Endocrinology and Metabolism, University of Würzburg, Würzburg, Germany
  • 5present address: Department of Neurology, Charité/Humboldt University, Berlin, Germany
Weitere Informationen

Publikationsverlauf

Received: January 31, 2001 First decision: June 20, 2001

Accepted: June 10, 2002

Publikationsdatum:
26. Februar 2003 (online)

Preview

Abstract

In this study, the human calcium-sensing receptor (CaR) stably expressed in HEK293 cells was investigated with regard to the phosphorylation-induced desensitization of its signaling pathway. The receptor is known to activate the phospholipase C/inositol-1,4,5-trisphosphate (IP3) signaling cascade, thus stimulating protein kinase C (PKC). In contrast, the adenylylcyclase/cAMP signaling pathway that activates protein kinase A (PKA) is believed to be coupled to the receptor via an inhibitory G-protein. We elucidated the roles of PKC and PKA by measuring Ca2+ o-stimulated accumulation of total inositol phosphates and by individually and simultaneously inhibiting the two kinases pharmacologically in HEK293 cells, which stably expressed the human CaR. Pharmacological inhibition of PKC resulted in a 5-fold enhancement of IP3 signaling, whereas blocking PKA had almost no effect. IP3 signaling activity increased even more (10-fold) however, when the two kinases were inhibited simultaneously. Apart from validating the role of PKC as a potent down-regulator of signaling of the human CaR in this cell system, this study suggests that both kinases synergize in inhibiting Ca2+ o-stimulated IP3 signaling in CaR-transfected HEK293 cells.

References

Priv.-Doz. Dr. Eberhard Blind

Department of Medicine - Endocrinology · University of Würzburg

Josef-Schneider-Str. 2

97080 Würzburg

Germany

Telefon: +49/93120136507

Fax: +49/93120136283

eMail: eberhard.blind@mail.uni-wuerzburg.de